Eads & Heald Wealth Management Gsk PLC Transaction History

Eads & Heald Wealth Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 26, 2022	SELL	$42.05 - $47.77 $210 - $238	-5 Reduced 0.08%	5,945 $263,000
Q1 2022 Apr 27, 2022	SELL	$40.23 - $47.74 $362 - $429	-9 Reduced 0.15%	5,950 $264,000
Q4 2021 Jan 31, 2022	BUY	$38.88 - $45.31 $5,715 - $6,660	147 Added 2.53%	5,959 $267,000
Q3 2021 Oct 27, 2021	BUY	$38.79 - $43.16 $225,447 - $250,845	5,812 New	5,812 $226,000
Q4 2017 Jan 31, 2018	SELL	$35.34 - $41.9 $220,804 - $261,791	-6,248 Closed	0 $0
Q3 2017 Oct 27, 2017	BUY	$39.44 - $41.55 $246,421 - $259,604	6,248	6,248 $0

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Eads & Heald Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Eads & Heald Wealth Management with notifications on news.